<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type-1 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> is associated with <z:mp ids='MP_0003674'>oxidative stress</z:mp> (OS) and <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Mechanistic links remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated changes in electrophysiological (EP) properties in a model of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> before and after challenge with OS by GSH oxidation and tested reversibility of EP remodeling by insulin </plain></SENT>
<SENT sid="3" pm="."><plain>Guinea pigs survived for 1 mo following <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ) or saline (sham) injection </plain></SENT>
<SENT sid="4" pm="."><plain>A treatment group received daily insulin for 2 wk to reverse STZ-induced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (STZ + Ins) </plain></SENT>
<SENT sid="5" pm="."><plain>EP properties were measured using high-resolution optical action potential mapping before and after challenge of hearts with <z:chebi fb="0" ids="48958">diamide</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Despite elevation of <z:chebi fb="105" ids="17234">glucose</z:chebi> levels in STZ compared with sham-operated (P = 0.004) and STZ + Ins (P = 0.002) animals, average action potential duration (APD) and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> propensity were not altered at baseline </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="48958">Diamide</z:chebi> promoted early (&lt;10 min) formation of arrhythmic triggers reflected by a higher <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> scoring index in STZ (P = 0.045) and STZ + Ins (P = 0.033) hearts compared with sham-operated hearts </plain></SENT>
<SENT sid="8" pm="."><plain>APD <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> underwent a more pronounced increase in response to <z:chebi fb="0" ids="48958">diamide</z:chebi> in STZ and STZ + Ins hearts compared with sham-operated hearts </plain></SENT>
<SENT sid="9" pm="."><plain>Within 30 min, <z:chebi fb="0" ids="48958">diamide</z:chebi> resulted in spontaneous incidence of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) in 3/6, 2/5, 1/5, and 0/4 STZ, STZ + Ins, sham-operated, and <z:mpath ids='MPATH_458'>normal</z:mpath> hearts, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>Hearts prone to VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> exhibited greater APD <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> (P = 0.010) compared with their VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>-free counterparts </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, altered EP properties in STZ were not rescued by insulin </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, GSH oxidation enhances APD <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> and increases <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> scoring index in a guinea pig model of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Despite normalization of glycemic levels by insulin, these proarrhythmic properties are not reversed, suggesting the importance of targeting <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defenses for <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> suppression </plain></SENT>
</text></document>